Clincosm LogoSign in Get a demo

cutaneous t cell lymphoma

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • +2 more
    • Ancona, Italy
    • +19 more
    Nov 2, 2023

    Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Fungoides Mycosis Sezary Syndrome
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    Jul 13, 2023

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • (no location specified)
    May 23, 2023

    Advanced Solid Tumor, Cutaneous T Cell Lymphoma Trial in Guanzhou (SIM1811-03)

    Recruiting
    • Advanced Solid Tumor
    • Cutaneous T Cell Lymphoma
    • Guanzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Mar 10, 2023

    Cutaneous T Cell Lymphoma Trial in Chicago (APR-TD011 (RLF-TD011))

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • APR-TD011 (RLF-TD011)
    • Chicago, Illinois
      Dermatology CTU
    Feb 6, 2023

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the

    Recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
    • THERAKOS® CELLEX photopheresis system
    • New York, New York
      Herbert Irving Pavilion
    Dec 23, 2022

    Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

    Active, not recruiting
    • Advanced Cancer
    • +16 more
    • Scottsdale, Arizona
    • +3 more
    Dec 22, 2022

    Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Mycosis Fungoides
    • (no location specified)
    Dec 7, 2022

    Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

    Recruiting
    • Cutaneous T Cell Lymphoma
    • Peripheral T Cell Lymphoma
    • Microdevices
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 16, 2022

    Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))

    Recruiting
    • Cutaneous T Cell Lymphoma
    • Micro needle array-Doxorubicin (MNA-D)
    • Pittsburgh, Pennsylvania
      University Of Pittsburgh Medical Center
    Jun 2, 2022

    Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

    Recruiting
    • Hematological Malignancies
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Apr 12, 2022

    Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)

    Completed
    • Cutaneous T Cell Lymphoma
    • +2 more
    • Leeds, United Kingdom
      Covance Clinical research Unit Ltd.
    Feb 3, 2022

    Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)

    Not yet recruiting
    • Mycosis Fungoides
    • Cutaneous T Cell Lymphoma
    • Low-dose total-skin electron-beam therapy
    • Phototherapy
    • (no location specified)
    Jan 24, 2022

    Characterization of the Microbiome in Cutaneous T Cell Lymphoma

    Recruiting
    • Cutaneous T Cell Lymphoma
      • Chicago, Illinois
        Northwestern University
      Oct 2, 2021

      Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With

      Active, not recruiting
      • Cutaneous T Cell Lymphoma
      • Graft Versus Host Disease
        • Lebanon, New Hampshire
          Dartmouth-Hitchcock Medical Center
        Aug 31, 2021

        Cutaneous T Cell Lymphoma Trial in Mannheim (dimethylfumarate)

        Unknown status
        • Cutaneous T Cell Lymphoma
        • Mannheim, Germany
          University Medical Center
        Sep 30, 2019

        STAT3 in T Cells: At The Crossroads of Inflammation and Cancer

        Terminated
        • Cutaneous T Cell Lymphoma
          • New York, New York
            NYU Langone Medical Center
          Sep 13, 2018

          Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in United States (Methoxsalen+ECP)

          Completed
          • Cutaneous T Cell Lymphoma
          • Mycosis Fungoides
          • Chicago, Illinois
          • +6 more
          Aug 15, 2018

          Psoriasis, Cutaneous T Cell Lymphoma, Lymphoproliferative Disorders Trial in Graz (Photo(chemo)therapy)

          Recruiting
          • Psoriasis
          • +10 more
          • Photo(chemo)therapy
          • Graz, Styria, Austria
            Medical University of Graz, Department of Dermatology
          Nov 7, 2017

          Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Australia, United States (Romidepsin)

          Completed
          Has Results
          • Cutaneous T Cell Lymphoma
          • Peripheral T Cell Lymphoma
          • Scottsdale, Arizona
          • +12 more
          Apr 13, 2017

          Cutaneous T Cell Lymphoma Trial in Paris (Blood sampling)

          Unknown status
          • Cutaneous T Cell Lymphoma
          • Blood sampling
          • Paris, France
            Saint Louis hospital
          Apr 15, 2016

          Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma Trial

          Completed
          • Peripheral T Cell Lymphoma Unspecified
          • +3 more
          • RAD001 (Everolimus)
          • Goyang-si, Kyoungki-do, Korea, Republic of
          • +4 more
          Mar 1, 2015